Gufic Biosciences Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Gufic Biosciences Limited Company Profile :

Gufic Biosciences Limited is an Indian company engaged in the business of manufacturing pharmaceuticals, medicinal chemicals and botanical products.

Company manufactures products in the areas of pharma, herbal/ayurvedic, consumer products and personal hygiene products. Its pharma products are Ridol Tablets, Vipro-Fe Syrup, Zad-G and Eben Tablets and Suspension. Its herbal/ayurvedic products are Sallaki tablets, Sallaki ointment, Imunocin tablets and syrup, Eugynin-L tablets, Aswal Plus tablets, and Kofend syrup. Its consumer products are Stretch Nil lotion, Roll-On cold rub oil, Care ointment and cream. Its personal hygiene products are Shapers and Actislim sanitary napkins.

Company also has a tissue culture facility for the production of around five million plants per annum. This tissue culture facility is used in the production of banana, potato, sugarcane, date palm, jatropha for Indian market.


Gufic Biosciences ResultsBSE Code : 509079
NSE Symbol : GUFICBIO
ISIN No. : INE742B01025
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Gufic Biosciences or you are an stock market analyst then i am sure you might for Quarterly Results of Gufic Biosciences.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Gufic Biosciences. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Gufic Biosciences.

Gufic Biosciences Q1 Results 2016-17 :

Gufic Biosciences will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT
Tax  –
Net Profit  –
Equity  –
EPS  –

Gufic Biosciences will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT
Tax  –
Net Profit  –
Equity  –
EPS  –

Gufic Biosciences will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT
Tax  –
Net Profit  –
Equity  –
EPS  –

Gufic Biosciences will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT
Tax  –
Net Profit  –
Equity  –
EPS  –

Gufic Biosciences will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT
Tax  –
Net Profit  –
Equity  –
EPS  –

Note : We will update the results table above as and when results are announced. Visit again.

Gufic Biosciences Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 202.32
Other Income  0.54  –
Total Income  202.86  –
Expenditure  -182.51  –
Interest  -5.37  –
Depreciation  -3.79  –
PBT  11.19  –
Tax  -3.87  –
Net Profit  7.32  –
Equity  7.74  –
EPS  0.95  –

Note : If you like this information about Gufic Biosciences Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.